Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Related Articles by Review for PubMed (Select 21393566)

1.

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.

Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, Garber J, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly M, Isaacs C, Stoppa-Lyonnet D, Sinilnikova OM, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA; GEMO Study Collaborators, Rookus MA, Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen J, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna H, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomassen M, Domchek S, Nathanson K, Caligo M, Jernström H, Liljegren A, Ehrencrona H, Karlsson P; SWE-BRCA, Ganz PA, Olopade OI, Tomlinson G, Neuhausen S, Antoniou AC, Chenevix-Trench G, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1032-8. doi: 10.1158/1055-9965.EPI-10-0909. Epub 2011 Mar 10.

2.

Is there more to BARD1 than BRCA1?

Irminger-Finger I, Jefford CE.

Nat Rev Cancer. 2006 May;6(5):382-91. Review.

PMID:
16633366
3.

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Friebel TM, Domchek SM, Rebbeck TR.

J Natl Cancer Inst. 2014 Jun;106(6):dju091. doi: 10.1093/jnci/dju091. Review. Erratum in: J Natl Cancer Inst. 2014 Aug;106(8):dju235 doi:10.1093/jnci/dju235.

4.

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.

Vargas AC, Da Silva L, Lakhani SR.

Fam Cancer. 2010 Dec;9(4):545-53. doi: 10.1007/s10689-010-9362-5. Review.

PMID:
20577821
5.

Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.

Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK.

Dtsch Arztebl Int. 2011 May;108(19):323-30. doi: 10.3238/arztebl.2011.0323. Epub 2011 May 13. Review.

6.

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.

Molina-Montes E, Pérez-Nevot B, Pollán M, Sánchez-Cantalejo E, Espín J, Sánchez MJ.

Breast. 2014 Dec;23(6):721-42. doi: 10.1016/j.breast.2014.10.005. Epub 2014 Nov 7. Review.

PMID:
25467311
7.

It is not all about BRCA: Cullin-Ring ubiquitin Ligases in ovarian cancer.

Carlucci A, D'Angiolella V.

Br J Cancer. 2015 Jan 6;112(1):9-13. doi: 10.1038/bjc.2014.594. Epub 2014 Dec 9. Review.

8.

Epigenetic changes in BRCA1-mutated familial breast cancer.

Downs B, Wang SM.

Cancer Genet. 2015 May;208(5):237-40. doi: 10.1016/j.cancergen.2015.02.001. Epub 2015 Feb 13. Review.

PMID:
25800897
9.

[Progress in the effects of BRAP gene on cardiovascular diseases].

Lv D, Zhu YM.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Sep;43(5):602-6. Review. Chinese.

PMID:
25372649
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk